Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Eur Respir J ; 39(2): 254-64, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-21700603

RESUMEN

It has recently been suggested that regular exercise reduces lung function decline and risk of chronic obstructive pulmonary disease (COPD) among active smokers; however, the mechanisms involved in this effect remain poorly understood. The present study evaluated the effects of regular exercise training in an experimental mouse model of chronic cigarette smoke exposure. Male C57BL/6 mice were divided into four groups (control, exercise, smoke and smoke+exercise). For 24 weeks, we measured respiratory mechanics, mean linear intercept, inflammatory cells and reactive oxygen species (ROS) in bronchoalveolar lavage (BAL) fluid, collagen deposition in alveolar walls, and the expression of antioxidant enzymes, matrix metalloproteinase 9, tissue inhibitor of metalloproteinase (TIMP)1, interleukin (IL)-10 and 8-isoprostane in alveolar walls. Exercise attenuated the decrease in pulmonary elastance (p<0.01) and the increase in mean linear intercept (p=0.003) induced by cigarette smoke exposure. Exercise substantially inhibited the increase in ROS in BAL fluid and 8-isoprostane expression in lung tissue induced by cigarette smoke. In addition, exercise significantly inhibited the decreases in IL-10, TIMP1 and CuZn superoxide dismutase induced by exposure to cigarette smoke. Exercise also increased the number of cells expressing glutathione peroxidase. Our results suggest that regular aerobic physical training of moderate intensity attenuates the development of pulmonary disease induced by cigarette smoke exposure.


Asunto(s)
Estrés Oxidativo/fisiología , Condicionamiento Físico Animal/fisiología , Enfermedad Pulmonar Obstructiva Crónica , Mecánica Respiratoria/fisiología , Contaminación por Humo de Tabaco/efectos adversos , Animales , Antioxidantes/metabolismo , Líquido del Lavado Bronquioalveolar/citología , Líquido del Lavado Bronquioalveolar/inmunología , Dinoprost/análogos & derivados , Dinoprost/metabolismo , Enfisema/etiología , Enfisema/fisiopatología , Enfisema/prevención & control , Interleucina-10/metabolismo , Macrófagos Alveolares/metabolismo , Masculino , Metaloproteinasa 9 de la Matriz/metabolismo , Ratones , Ratones Endogámicos C57BL , Alveolos Pulmonares/metabolismo , Alveolos Pulmonares/fisiopatología , Enfermedad Pulmonar Obstructiva Crónica/etiología , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Enfermedad Pulmonar Obstructiva Crónica/prevención & control , Especies Reactivas de Oxígeno/metabolismo , Inhibidor Tisular de Metaloproteinasa-1/metabolismo
2.
Inhal Toxicol ; 22(7): 610-7, 2010 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-20429853

RESUMEN

Diesel exhaust is the major source of ultrafine particles released during traffic-related pollution. Subjects with chronic respiratory diseases are at greater risk for exacerbations during exposure to air pollution. This study evaluated the effects of subchronic exposure to a low-dose of diesel exhaust particles (DEP). Sixty male BALB/c mice were divided into two groups: (a) Saline: nasal instillation of saline (n = 30); and (b) DEP: nasal instillation of 30 microg of DEP/10 microl of saline (n = 30). Nasal instillations were performed 5 days a week, over 30 and 60 days. Animals were anesthetized with pentobarbital sodium (50 mg/kg intraperitoneal [i.p.]) and sacrificed by exsanguination. Bronchoalveolar lavage (BAL) fluid was performed to evaluate the inflammatory cell count and the concentrations of the interleukin (IL)-4, IL-10, and IL-13 by enzyme-linked immunosorbent assay (ELISA). The gene expression of oligomeric mucus/gel-forming (Muc5ac) was evaluated by real-time polymerase chain reaction (PCR). Histological analysis in the nasal septum and bronchioles was used to evaluate the bronchial and nasal epithelium thickness as well as the acidic and neutral nasal mucus content. The saline group (30 and 60 days) did not show any changes in any of the parameters. However, the instillation of DEP over 60 days increased the expression of Muc5ac in the lungs and the acid mucus content in the nose compared with the 30-day treatment, and it increased the total leukocytes in the BAL and the nasal epithelium thickness compared with saline for 60 days. Cytokines concentrations in the BAL were detectable, with no differences among the groups. Our data suggest that a low-dose of DEP over 60 days induces respiratory tract inflammation.


Asunto(s)
Exposición por Inhalación/efectos adversos , Material Particulado/administración & dosificación , Material Particulado/efectos adversos , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/patología , Emisiones de Vehículos , Administración Intranasal , Contaminantes Atmosféricos/efectos adversos , Animales , Líquido del Lavado Bronquioalveolar , Inflamación/inducido químicamente , Inflamación/patología , Pulmón/efectos de los fármacos , Pulmón/patología , Masculino , Ratones , Ratones Endogámicos BALB C
3.
Int J Sports Med ; 31(12): 906-12, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21072743

RESUMEN

Airway epithelium plays important roles in the pathophysiology of asthma. Creatine supplementation (Cr) was shown to increase asthma features in a murine model of allergic asthma; however, the role of the airway epithelium in this inflammatory response is not known. BALB/c mice were divided into control, creatine supplementation, ovalbumin-sensitized (OVA) and OVA plus creatine supplementation groups. OVA sensitization occurred on days 0, 14, 28 and 42, and ovalbumin challenge from days 21-53. Cr was also given on days 21-53. Total and differential cells counts in BALF were evaluated. Quantitative epithelial expression of interleukin (IL)-4, IL-5, IL-13, CCL11, CCL5, CCL2, iNOS, VCAM-1, ICAM-1, NF-κB, VEGF, TGF-ß, IGF-1, EGFR, TIMP-1, TIMP-2, MMP-9, MMP-12 and arginase II were performed. Cr increased the number of total cells and eosinophils in BALF, the epithelial content of goblet cells and the epithelial expression of IL-5, CCL2, iNOS, ICAM-1, NF-κB, TGF-ß, TIMP-1 and MMP-9 when compared to the control group (p<0.05). Creatine supplementation also exacerbated goblet cell proliferation, and IL-5 and iNOS expression by epithelial cells compared to the OVA group (p<0.01). Creatine up-regulates the pro-inflammatory cascade and remodelling process in this asthma model by modulating the expression of inflammatory mediators by epithelial cells.


Asunto(s)
Asma/etiología , Creatina/toxicidad , Células Epiteliales/metabolismo , Mediadores de Inflamación/metabolismo , Animales , Asma/fisiopatología , Líquido del Lavado Bronquioalveolar/química , Proliferación Celular/efectos de los fármacos , Modelos Animales de Enfermedad , Células Epiteliales/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Células Caliciformes/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos BALB C , Ovalbúmina , Factores de Tiempo
4.
Surgery ; 84(6): 775-83, 1978 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-715697

RESUMEN

Because arteriosclerotic popliteal aneurysms so often present with complications, treatment results are less than optimal in contrast to aneurysms oat other sites. From 1963 to 1977, 40 surgically treated aneurysms in 30 patients were studied. Seventeen limbs presented as asymptomatic aneurysms (42.5%), four with pressure symptoms (10%), one with rupture and ischemia (2.5%), nine with acute thromboses and ischemia (22.5%), and nine with chronic ischemia and claudication (22.5%). Seventeen aneurysms were thrombosed (42.5%). Diameters of all aneurysms measured at operation ranged from 1.0 to 10 cm. It was of interest to note that, generally, larger aneurysms were patent, and thromboses were common in the smaller aneurysms, with an average diameter of 2.5 cm. Saphenous vein grafts were used most frequently for interpolation grafts (65%) and bypass grafts (12.5(). Prosthesis were used in 7.5%, endarterectomy and aneurysmorraphy in 5%. Popliteal reconstruction was accomplished initially in 40 limbs, with two early failures and 10 late failures with loss of two limbs. Cumulative patency rates for 40 limbs at risk at 5 and 10 years were 75.9%, at 14 years, 62.6%. Diagnosis is the most difficult aspect of this problem, as physical limitations impede early diagnosis. Thromboses being the natural history of popliteal aneurysms, early recognition and treatment are important to improve limb salvage rates.


Asunto(s)
Aneurisma/cirugía , Arteria Poplítea , Enfermedad Aguda , Amputación Quirúrgica , Aneurisma/complicaciones , Arteriopatías Oclusivas/complicaciones , Arteriosclerosis/complicaciones , Prótesis Vascular/efectos adversos , Endarterectomía , Humanos , Isquemia/cirugía , Pierna/irrigación sanguínea , Pierna/cirugía , Arteria Poplítea/cirugía , Complicaciones Posoperatorias , Rotura Espontánea , Vena Safena/trasplante , Trombosis/cirugía , Trasplante Autólogo/efectos adversos
5.
Braz J Infect Dis ; 5(3): 154-7, 2001 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-11506779

RESUMEN

This is a case report of a 29 year old male with pneumocystis pneumonia and tuberculosis, and who was initially suspected of having HIV infection, based on risk factor analyses, but was subsequently shown to be HIV negative. The patient arrived at the hospital with fever, cough, weight loss, loss of appetite, pallor, and arthralgia. In addition, he was jaundiced and had cervical lymphadenopathy and mild heptosplenomegaly. He had interstitial infiltrates of the lung, sputum smears positive for Mycobacterium tuberculosis and Pneumocystis carinii, and stool tests were positive for Strongyloides stercoralis and Schistosoma mansoni. He was diagnosed as having AIDS, and was treated for tuberculosis, pneumocystosis, and strongyloidiasis with a good response. The patient did not receive anti-retroviral therapy, pending outcome of the HIV tests. A month later, he was re-examined and found to have worsening hepatosplenomegaly, pancytopenia, fever, and continued weight loss. At this time, it was determined that his HIV ELISA antibody tests were negative. A bone marrow aspirate was done and revealed amastigotes of leishmania, and a bone marrow culture was positive for Leishmania species. He was treated with pentavalent antimony, 20 mg daily for 20 days, with complete remission of symptoms and weight gain. This case demonstrates that immunosuppression from leishmaniasis and tuberculosis may lead to pneumocystosis, and be misdiagnosed as HIV infection. The occurrence of opportunistic infections in severely ill patients without HIV must always be considered and alternate causes of immunosuppression sought.


Asunto(s)
Seronegatividad para VIH , Leishmaniasis/complicaciones , Neumonía por Pneumocystis/complicaciones , Tuberculosis Pulmonar/complicaciones , Síndrome de Inmunodeficiencia Adquirida/diagnóstico , Adulto , Errores Diagnósticos , Humanos , Masculino , Mycobacterium tuberculosis/aislamiento & purificación , Pneumocystis/aislamiento & purificación , Esputo/microbiología
6.
Histol Histopathol ; 28(2): 269-76, 2013 02.
Artículo en Inglés | MEDLINE | ID: mdl-23275309

RESUMEN

A single instillation of porcine pancreatic elastase (PPE) results in significant airspace enlargement on the 28th day after instillation, whereas cigarette smoke (CS) exposure requires 6 months to produce mild emphysema in rodents. Considering that there are differences in the pathogenesis of parenchymal destruction in these different experimental models, it is likely that there may be different patterns of extracellular matrix (ECM) remodeling. To evaluate ECM remodeling, C57BL/6 mice were submitted to either a nasal drop of PPE (PPE 28 Days) or exposed for 6 months to cigarette smoke (CS 6 months). Control groups received either an intranasal instillation of saline solution (Saline 28 Days) or remained without any smoke inhalation for six months (Control 6 months). We measured the mean linear intercept and the volume proportion of collagen type I, collagen type III, elastin and fibrillin. We used emission-scanning confocal microscopy to verify the fiber distribution. Both models induced increased mean linear intercept in relation to the respective controls, being larger in the elastase model in relation to the CS model. In the CS model, emphysema was associated with an increase in the volume proportion of fibrillin, whereas in the PPE model there was an increase in the parenchymal elastin content. In both models, there was an increase in collagen type III, which was higher in the CS-exposed mice. We concluded that ECM remodeling is different in the two most used experimental models of emphysema.


Asunto(s)
Modelos Animales de Enfermedad , Enfisema/inducido químicamente , Enfisema/patología , Matriz Extracelular/metabolismo , Matriz Extracelular/patología , Elastasa Pancreática/efectos adversos , Fumar/efectos adversos , Animales , Colágeno Tipo I/metabolismo , Colágeno Tipo III/metabolismo , Elastina/metabolismo , Enfisema/metabolismo , Fibrilinas , Inmunohistoquímica/métodos , Pulmón/metabolismo , Pulmón/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Proteínas de Microfilamentos/metabolismo , Microscopía Confocal , Porcinos
7.
Br J Pharmacol ; 168(7): 1736-49, 2013 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-23170811

RESUMEN

BACKGROUND AND PURPOSE: Asthma is an inflammatory disease that involves airway hyperresponsiveness and remodelling. Flavonoids have been associated to anti-inflammatory and antioxidant activities and may represent a potential therapeutic treatment of asthma. Our aim was to evaluate the effects of the sakuranetin treatment in several aspects of experimental asthma model in mice. EXPERIMENTAL APPROACH: Male BALB/c mice received ovalbumin (i.p.) on days 0 and 14, and were challenged with aerolized ovalbumin 1% on days 24, 26 and 28. Ovalbumin-sensitized animals received vehicle (saline and dimethyl sulfoxide, DMSO), sakuranetin (20 mg kg(-1) per mice) or dexamethasone (5 mg kg(-1) per mice) daily beginning from 24th to 29th day. Control group received saline inhalation and nasal drop vehicle. On day 29, we determined the airway hyperresponsiveness, inflammation and remodelling as well as specific IgE antibody. RANTES, IL-5, IL-4, Eotaxin, IL-10, TNF-α, IFN-γ and GMC-SF content in lung homogenate was performed by Bioplex assay, and 8-isoprostane and NF-kB activations were visualized in inflammatory cells by immunohistochemistry. KEY RESULTS: We have demonstrated that sakuranetin treatment attenuated airway hyperresponsiveness, inflammation and remodelling; and these effects could be attributed to Th2 pro-inflammatory cytokines and oxidative stress reduction as well as control of NF-kB activation. CONCLUSIONS AND IMPLICATIONS: These results highlighted the importance of counteracting oxidative stress by flavonoids in this asthma model and suggest sakuranetin as a potential candidate for studies of treatment of asthma.


Asunto(s)
Remodelación de las Vías Aéreas (Respiratorias)/efectos de los fármacos , Antiinflamatorios/farmacología , Asma/tratamiento farmacológico , Flavonoides/farmacología , Animales , Antiinflamatorios/uso terapéutico , Asma/inmunología , Asma/fisiopatología , Líquido del Lavado Bronquioalveolar/citología , Citocinas/metabolismo , Flavonoides/uso terapéutico , Inflamación/tratamiento farmacológico , Inflamación/inmunología , Pulmón/inmunología , Pulmón/patología , Pulmón/fisiopatología , Masculino , Ratones , Ratones Endogámicos BALB C , FN-kappa B/metabolismo , Ovalbúmina/inmunología , Estrés Oxidativo/efectos de los fármacos
8.
Braz J Med Biol Res ; 44(5): 460-8, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-21445523

RESUMEN

Chronic obstructive pulmonary disease (COPD) is associated with inflammatory cell reactions, tissue destruction and lung remodeling. Many signaling pathways for these phenomena are still to be identified. We developed a mouse model of COPD to evaluate some pathophysiological mechanisms acting during the initial stage of the disease. Forty-seven 6- to 8-week-old female C57/BL6 mice (approximately 22 g) were exposed for 2 months to cigarette smoke and/or residual oil fly ash (ROFA), a concentrate of air pollution. We measured lung mechanics, airspace enlargement, airway wall thickness, epithelial cell profile, elastic and collagen fiber deposition, and by immunohistochemistry transforming growth factor-ß1 (TGF-ß1), macrophage elastase (MMP12), neutrophils and macrophages. We observed regional airspace enlargements near terminal bronchioles associated with the exposure to smoke or ROFA. There were also increases in airway resistance and thickening of airway walls in animals exposed to smoke. In the epithelium, we noted a decrease in the ciliated cell area of animals exposed to smoke and an increase in the total cell area associated with exposure to both smoke and ROFA. There was also an increase in the expression of TGF-ß1 both in the airways and parenchyma of animals exposed to smoke. However, we could not detect inflammatory cell recruitment, increases in MMP12 or elastic and collagen fiber deposition. After 2 months of exposure to cigarette smoke and/or ROFA, mice developed regional airspace enlargements and airway epithelium remodeling, although no inflammation or increases in fiber deposition were detected. Some of these phenomena may have been mediated by TGF-ß1.


Asunto(s)
Remodelación de las Vías Aéreas (Respiratorias)/fisiología , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Mucosa Respiratoria/fisiopatología , Contaminación por Humo de Tabaco/efectos adversos , Animales , Arteriolas/patología , Colágeno/metabolismo , Modelos Animales de Enfermedad , Femenino , Inmunohistoquímica , Ratones , Ratones Endogámicos C57BL , Músculo Liso Vascular/patología , Enfermedad Pulmonar Obstructiva Crónica/etiología , Enfermedad Pulmonar Obstructiva Crónica/patología , Mucosa Respiratoria/patología , Factores de Tiempo , Factor de Crecimiento Transformador beta/metabolismo
10.
Braz. j. med. biol. res ; 44(5): 460-468, May 2011. ilus
Artículo en Inglés | LILACS | ID: lil-586504

RESUMEN

Chronic obstructive pulmonary disease (COPD) is associated with inflammatory cell reactions, tissue destruction and lung remodeling. Many signaling pathways for these phenomena are still to be identified. We developed a mouse model of COPD to evaluate some pathophysiological mechanisms acting during the initial stage of the disease. Forty-seven 6- to 8-week-old female C57/BL6 mice (approximately 22 g) were exposed for 2 months to cigarette smoke and/or residual oil fly ash (ROFA), a concentrate of air pollution. We measured lung mechanics, airspace enlargement, airway wall thickness, epithelial cell profile, elastic and collagen fiber deposition, and by immunohistochemistry transforming growth factor-β1 (TGF-β1), macrophage elastase (MMP12), neutrophils and macrophages. We observed regional airspace enlargements near terminal bronchioles associated with the exposure to smoke or ROFA. There were also increases in airway resistance and thickening of airway walls in animals exposed to smoke. In the epithelium, we noted a decrease in the ciliated cell area of animals exposed to smoke and an increase in the total cell area associated with exposure to both smoke and ROFA. There was also an increase in the expression of TGF-β1 both in the airways and parenchyma of animals exposed to smoke. However, we could not detect inflammatory cell recruitment, increases in MMP12 or elastic and collagen fiber deposition. After 2 months of exposure to cigarette smoke and/or ROFA, mice developed regional airspace enlargements and airway epithelium remodeling, although no inflammation or increases in fiber deposition were detected. Some of these phenomena may have been mediated by TGF-β1.


Asunto(s)
Animales , Femenino , Ratones , Remodelación de las Vías Aéreas (Respiratorias)/fisiología , Enfermedad Pulmonar Obstructiva Crónica/fisiopatología , Mucosa Respiratoria/fisiopatología , Contaminación por Humo de Tabaco/efectos adversos , Arteriolas/patología , Colágeno/metabolismo , Modelos Animales de Enfermedad , Inmunohistoquímica , Músculo Liso Vascular/patología , Enfermedad Pulmonar Obstructiva Crónica/etiología , Enfermedad Pulmonar Obstructiva Crónica/patología , Mucosa Respiratoria/patología , Factores de Tiempo , Factor de Crecimiento Transformador beta/metabolismo
11.
Ann Surg ; 188(1): 43-8, 1978 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-666376

RESUMEN

Segmental occlusive disease though limited to the popliteal artery gives rise to significant ischemic symptoms such that surgical treatment is indicated. Endarterectomy with vein angioplasty was the primary procedure in 76 patients (79 limbs) over the past 15 years. Augmentive lumbar sympathectomy was performed in 30 patients. Endarterectomy restoration was successful in 73 patients (76 limbs). Acute postoperative thrombosis occurred in six limbs, four were restored, one survived, one underwent delayed amputation. Long term failures developed in 18 limbs, four were restored, 11 survived without further treatment, and three were amputated. All limbs were classified according to stages of outflow obstruction and extent of endarterectomy; however, there was no meaningful pattern of correlation with failures except to note that amputations occurred only in advanced stage III obstructions. Thirty-two patients (43%) were restudied by arteriography. Cumulative patency rate for 79 limbs at risk at five years was 75.6%, at ten years, 58.5%. Restoration of popliteal patency can be accomplished by endarterectomy with results comparable to femoral-popliteal saphenous vein graft for more proximal lesions. Endarterectomy affords the advantage that a bypass procedure can still be performed in most failures as the long saphenous vein, not sacrificed initially, is still available.


Asunto(s)
Arteriopatías Oclusivas/cirugía , Endarterectomía , Arteria Poplítea/cirugía , Adulto , Anciano , Femenino , Arteria Femoral/cirugía , Humanos , Pierna/irrigación sanguínea , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias , Riesgo , Vena Safena/trasplante , Simpatectomía , Trombosis/epidemiología , Trasplante Autólogo
12.
Mem Inst Oswaldo Cruz ; 95(4): 437-43, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-10904397

RESUMEN

The objective of this study was to identify tuberculosis risk factors and possible surrogate markers among human immunodeficiency virus (HIV)-infected persons. A retrospective case-control study was carried out at the HIV outpatient clinic of the Universidade Federal de Minas Gerais in Belo Horizonte. We reviewed the demographic, social-economical and medical data of 477 HIV-infected individuals evaluated from 1985 to 1996. The variables were submitted to an univariate and stratified analysis. Aids related complex (ARC), past history of pneumonia, past history of hospitalization, CD4 count and no antiretroviral use were identified as possible effect modifiers and confounding variables, and were submitted to logistic regression analysis by the stepwise method. ARC had an odds ratio (OR) of 3.5 (CI 95% - 1.2-10.8) for tuberculosis development. Past history of pneumonia (OR 1.7 - CI 95% 0.6-5.2) and the CD4 count (OR 0.4 - CI 0. 2-1.2) had no statistical significance. These results show that ARC is an important clinical surrogate for tuberculosis in HIV-infected patients. Despite the need of confirmation in future studies, these results suggest that the ideal moment for tuberculosis chemoprophylaxis could be previous to the introduction of antiretroviral treatment or even just after the diagnosis of HIV infection.


Asunto(s)
Complejo Relacionado con el SIDA/epidemiología , Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Tuberculosis Pulmonar/epidemiología , Complejo Relacionado con el SIDA/diagnóstico , Adolescente , Adulto , Sesgo , Biomarcadores , Brasil/epidemiología , Estudios de Casos y Controles , Intervalos de Confianza , Femenino , Humanos , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Estudios Retrospectivos , Factores de Riesgo , Tuberculosis Pulmonar/etiología , Tuberculosis Pulmonar/prevención & control
18.
Rev. bras. farmacogn ; 13(supl.2): 1-2, 2003.
Artículo en Portugués | LILACS | ID: lil-526474

RESUMEN

Conhecido popularmente pelo nome de confrei e recomendado como medicamento fitoterápico pela RDC nº 17 de 25/02/00 da ANVISA, Symphytum officinale L. (Boraginaceae) vem sendo utilizado por diferentes populações desde 2000 AC, com o intuito de consolidar ossos fraturados e cicatrizar feridas. O objetivo deste trabalho foi apresentar subsídios ao controle de qualidade da indústria farmacêutica na produção do fitoterápico de uso tópico, à base de folhas de confrei. Procedeu-se à identificação morfo-anatômica foliar da planta medicinal e a droga vegetal foi submetida à determinação de água, resíduo seco e cinzas totais e insolúveis em ácido. Os extratos etanólico e aquoso foram ensaiados em triplicata, quanto à análise organoléptica, determinação de pH e resíduo seco, detecção de grupos químicos e quantificação do princípio ativo alantoína.


Known popularly by the confrei name and recommended as phytomedicine by Anvisa RDC n.º 17 Act of 25/02/00, Symphytum officinale L. (Boraginaceae) it comes being used by different populations from 2000 AC, with the aim of to consolidate fractured bones and to heal wounds. The objective of this work went present subsidies to the control of quality of the pharmaceutical industry in the production of the phytomedicine of topical use, to the base of confrei leaves. It was proceeded to the morphological and anatomical identification to foliate of the medicinal plant and the vegetable drug was submitted to the determination of water, dry residue and total and insoluble ashes in acid. The etanolic and aqueous extracts were rehearsed in triplicate, with relationship to the sensorial analysis, pH determination and dry residue, detection of chemical groups and quantification of the beginning active allantoin.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA